RAPID AND SAFE DELIVERY OF OUTBREAK RESEARCH

We rapidly and safely unlock the value of novel vaccines and therapeutics for emerging and re-emerging infectious diseases.

Conducting clinical retrials during an outbreak can be challenging, requiring the ability to recruit and enroll participants quickly while ensuring their safety and those of staff in a rapidly evolving public health emergency.

Our expertise in outbreak clinical trials and response sets us apart.

  • Overcome outbreak R&D pre-approved adaptive design protocol.

  • Prequalified sites with the highest likelihood of the next outbreak.
  • Remote site monitoring for safety,  compliance, and quality of data.
  • Interim analysis for early detection of treatment effect.
  • Biological material transfer for end-point analysis at central labs.

Stay ahead of the outbreak using our proven pandemic response and preparedness playbook.

COVID-19

Leverage ACE Research Expertise and Resources to Safely Deliver COVID-19 Clinical Trials

LAB

Biological Material Transfer